Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canagliflozin for cognitive function in type 2 diabetes
NCT04304261Phase 3Completed
- Sponsor
- Army Medical University
- Start
- Jul 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of canagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Army Medical University. Started Jul 2021; status: completed.
02
Drugs
canagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04304261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04304261.